Skip to main content
. Author manuscript; available in PMC: 2023 Oct 15.
Published in final edited form as: Stem Cell Res. 2023 Apr 15;69:103098. doi: 10.1016/j.scr.2023.103098
Unique stem cell lines identifier Cell line 1: CHOPi008-A
Cell line 2: CHOPi008-C
Alternative name(s) of stem cell lines Cell line 1: TMD145.T21.G1S
Cell line 2: DS145.T21.G1
Institution Children’s Hospital of Philadelphia
Contact information of distributor Stella T. Chou, MD
chous@chop.edu
Type of cell lines iPSC
Origin Human
Additional origin info Age: 8 days
Sex: Male
Ethnicity if known: White
Cell Source Peripheral blood
Clonality Clonal
Method of reprogramming Sendai virus
Genetic Modification Yes
Type of Genetic Modification Spontaneous mutation/chromosomal abnormality (germline Trisomy 21 with and without somatic GATA1 mutation)
Evidence of the reprogramming transgene loss (including genomic copy if applicable) qRT-PCR
Associated disease Transient myeloproliferative disorder
Gene/locus CHOPi008-A: GATA1 c.3_4insG (GATA1s)
CHOPi008-C: GATA1
Date archived/stock date August 2022
Cell line repository/bank https://hpscreg.eu/cell-line/CHOPi008-A
https://hpscreg.eu/cell-line/CHOPi008-C
Ethical approval Children’s Hospital of Philadelphia, Committees for the Protection of Human Subjects (IRB), IRB 13-010038